JP2014240383A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014240383A5 JP2014240383A5 JP2014102285A JP2014102285A JP2014240383A5 JP 2014240383 A5 JP2014240383 A5 JP 2014240383A5 JP 2014102285 A JP2014102285 A JP 2014102285A JP 2014102285 A JP2014102285 A JP 2014102285A JP 2014240383 A5 JP2014240383 A5 JP 2014240383A5
- Authority
- JP
- Japan
- Prior art keywords
- mirtazapine
- cancer
- subject
- acceptable salt
- pharmacologically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010028980 Neoplasm Diseases 0.000 claims 15
- 201000011510 cancer Diseases 0.000 claims 15
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 claims 12
- 229960001785 mirtazapine Drugs 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 10
- 239000012453 solvate Substances 0.000 claims 10
- 239000002257 antimetastatic agent Substances 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 2
- 230000001093 anti-cancer Effects 0.000 claims 2
- 102000016362 Catenins Human genes 0.000 claims 1
- 108010067316 Catenins Proteins 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 239000012830 cancer therapeutic Substances 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000009401 metastasis Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014102285A JP6452954B2 (ja) | 2013-05-16 | 2014-05-16 | 癌転移抑制剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013104409 | 2013-05-16 | ||
| JP2013104409 | 2013-05-16 | ||
| JP2014102285A JP6452954B2 (ja) | 2013-05-16 | 2014-05-16 | 癌転移抑制剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014240383A JP2014240383A (ja) | 2014-12-25 |
| JP2014240383A5 true JP2014240383A5 (enrdf_load_stackoverflow) | 2017-07-06 |
| JP6452954B2 JP6452954B2 (ja) | 2019-01-16 |
Family
ID=52139848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014102285A Expired - Fee Related JP6452954B2 (ja) | 2013-05-16 | 2014-05-16 | 癌転移抑制剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6452954B2 (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6915865B2 (ja) * | 2017-10-03 | 2021-08-04 | 学校法人 愛知医科大学 | Ｎｏ産生抑制剤及び固形腫瘍に対する転移・浸潤抑制剤 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200808804A (en) * | 2006-05-22 | 2008-02-16 | Organon Nv | Mirtazapine for the treatment of neuropathic pain |
-
2014
- 2014-05-16 JP JP2014102285A patent/JP6452954B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2016004305A3 (en) | Inhibitors of bruton's tyrosine kinase | |
| CY1120941T1 (el) | Παραγωγα φαινυλοτριαζολιου υποκατεστημενα με υδροξυαλκυλιο και χρησεις αυτων | |
| MX2022001755A (es) | Compuestos de dinucleotidos ciclicos y metodos de uso. | |
| CY1125326T1 (el) | Προαιρετικως συντηγμενα ετεροκυκλυλο- υποκατεστημενα παραγωγα πυριμιδινης χρησιμα για τη θεραπευτικη αγωγη φλεγμονωδων, μεταβολικων, ογκολογικων και αυτοανοσων ασθενειων. | |
| PH12018500284A1 (en) | 5-bromo-2,6-di-(1h-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer | |
| WO2016196776A3 (en) | Inhibitors of bruton's tyrosine kinase | |
| ZA201800022B (en) | Substituted heterocyclyl derivatives as cdk inhibitors | |
| MX375752B (es) | Inhibidores de tirosina quinasa de bruton. | |
| PH12016500575A1 (en) | Inhibitors of bruton`s tyrosine kinase | |
| WO2015148415A3 (en) | Use of the fl118 core chemical structure platform to generate fl118 derivatives for treatment of human disease | |
| MY187047A (en) | Selective pyy compounds and uses thereof | |
| WO2015106128A3 (en) | Rnai agents modified at the 4'-c-position | |
| NZ728392A (en) | High dosage strength tablets of rucaparib | |
| MA34019B1 (fr) | Aryltriazolone liée à un bis-aryle et son utilisation | |
| PH12016500420A1 (en) | Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt | |
| PH12016502353A1 (en) | Pharmaceutical composition | |
| MX2020011100A (es) | Compuestos, composiciones farmaceuticas y metodos de uso de agonistas de ppar. | |
| EA201691918A1 (ru) | Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения | |
| EA201691674A1 (ru) | 1,2-замещенные циклопентаны в качестве антагонистов рецептора орексина | |
| JP2015502926A5 (enrdf_load_stackoverflow) | ||
| JOP20190263A1 (ar) | عوامل RNAi لتثبيط التعبير عن Alpha- EnaC وطرق استخدامها | |
| TW201613577A (en) | Pharmaceutical combinations | |
| CL2014001959A1 (es) | Compuestos derivados de fenil-1h-imidazo[1,2-b]pirazol sustituidos; procedimiento de preparacion; composicion farmaceutica; y el uso en el tratamiento del cancer. | |
| UA116499C2 (uk) | (r)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині | |
| JP2014240383A5 (enrdf_load_stackoverflow) |